IBRX: ImmunityBio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5,359.65
Enterprise Value ($M) 6,078.74
Book Value ($M) -690.98
Book Value / Share -1.00
Price / Book -7.76
NCAV ($M) -895.94
NCAV / Share -1.30
Price / NCAV -5.98

Profitability (mra)
Return on Invested Capital (ROIC) -2.94
Return on Assets (ROA) -1.75
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.64
Current Ratio 3.64

Balance Sheet (mrq) ($M)
Current Assets 195.72
Assets 400.68
Liabilities 1,091.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.62
Operating Income -361.36
Net Income -583.20
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -366.76
Cash from Investing -30.47
Cash from Financing 558.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-04 13D/A Cambridge Equities, LP 83.50 7.07

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 1,221,642 4,138,342 29.52
2024-05-16 1,191,176 4,205,950 28.32
2024-05-15 1,130,036 4,694,768 24.07
2024-05-14 2,088,802 6,866,991 30.42
2024-05-13 1,597,262 6,184,298 25.83

(click for more detail)

Similar Companies
HLVX – HilleVax, Inc. HOWL – Werewolf Therapeutics, Inc.
HUMA – Humacyte, Inc. IDXX – IDEXX Laboratories, Inc.
IDYA – IDEAYA Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io